BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 3, 2010
View Archived Issues
Azathioprine and prednisolone reduce relapse rates in neuromyelitis optica
Read More
Antibodies targeting LINGO-1 promote myelination in preclinical studies
Read More
Manageable toxicity seen with brivanib alaninate plus cetuximab and irinotecan in colorectal cancer
Read More
New modulators of G protein-coupled receptors disclosed
Read More
QLT expands phase Ib study of QLT-091001 to include patients with retinitis pigmentosa
Read More
Afatinib is active in patients with head and neck and lung cancers
Read More
Clinical data reported on cilengitide in NSCLC and glioblastoma
Read More
Incuron initiates phase Ib trial of Curaxin CBLC-102 in liver tumors
Read More
Orphan drug status granted for PRX-8066 in PAH
Read More
Merck KGaA describes novel E-NPP 2 inhibitors
Read More
Cipher completes patient enrollment in phase III CIP-Isotretinoin study
Read More
New benzoxazole derivatives disclosed by BioMarin IGA
Read More
Protalix BioTherapeutics reports on taliglucerase alfa switchover trial
Read More
NuPathe submits Zelrix NDA to FDA for migraine
Read More
Novartis and Xenon Pharma claim new acyl-CoA desaturase inhibitors
Read More
FDA responds to Biodel regarding Linjeta NDA
Read More
New neuropeptide Y5 receptor antagonists discovered
Read More
Compugen licenses MAb-based oncology target to Seattle Genetics
Read More
VaxGen changes name to diaDexus
Read More
NeoPharm merges with Insys Therapeutics
Read More
Cell Therapeutics submits MAA to EMA for Pixuvri in NHL
Read More
Genta receives EMA advice for phase III tesetaxel trial in gastric cancer
Read More
Covance and sanofi-aventis enter 10-year strategic collaboration
Read More
FDA orphan drug status for ensituximab in pancreatic cancer
Read More
FluCide extends survival of animals in influenza study
Read More
GSK receives Japanese approval for Revolade and Xyzal
Read More